UY27715A1 - Progestinas no esteroides. - Google Patents
Progestinas no esteroides.Info
- Publication number
- UY27715A1 UY27715A1 UY27715A UY27715A UY27715A1 UY 27715 A1 UY27715 A1 UY 27715A1 UY 27715 A UY27715 A UY 27715A UY 27715 A UY27715 A UY 27715A UY 27715 A1 UY27715 A1 UY 27715A1
- Authority
- UY
- Uruguay
- Prior art keywords
- progestines
- steroid
- derivative
- analog
- acceptable
- Prior art date
Links
- 239000000583 progesterone congener Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/87—Benzo [c] furans; Hydrogenated benzo [c] furans
- C07D307/88—Benzo [c] furans; Hydrogenated benzo [c] furans with one oxygen atom directly attached in position 1 or 3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/30—Oestrogens
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
- C07D265/02—1,2-Oxazines; Hydrogenated 1,2-oxazines
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Gynecology & Obstetrics (AREA)
- Pregnancy & Childbirth (AREA)
- Diabetes (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Furan Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US36304402P | 2002-03-11 | 2002-03-11 | |
| EP02005530A EP1344776A1 (en) | 2002-03-11 | 2002-03-11 | 5- 2-hydroxy-3-[1-(3-trifluoromethylphenyl)-cyclopropyl]-propionylamino -phtalide and 6- 2-hydroxy-3-[1-(3-trifluoromethylphenyl)-cyclopropyl]-propionylamino -4-methyl-2,3-benzoxazin-1-one derivatives with progesterone receptor modulating activity for use in fertility control, hormone replacement therapy and the treatment of gynecological disorders |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| UY27715A1 true UY27715A1 (es) | 2003-08-29 |
Family
ID=27806515
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| UY27715A UY27715A1 (es) | 2002-03-11 | 2003-03-11 | Progestinas no esteroides. |
Country Status (26)
| Country | Link |
|---|---|
| US (1) | US7388006B2 (OSRAM) |
| EP (1) | EP1482925B1 (OSRAM) |
| JP (1) | JP2005526064A (OSRAM) |
| CN (1) | CN1652768A (OSRAM) |
| AR (1) | AR035904A1 (OSRAM) |
| AU (1) | AU2003209720A1 (OSRAM) |
| BR (1) | BR0308394A (OSRAM) |
| CA (1) | CA2478948A1 (OSRAM) |
| CR (1) | CR7490A (OSRAM) |
| DE (1) | DE60311236T2 (OSRAM) |
| DK (1) | DK1482925T3 (OSRAM) |
| ES (1) | ES2280766T3 (OSRAM) |
| HR (1) | HRP20040923A2 (OSRAM) |
| IL (1) | IL164032A0 (OSRAM) |
| MX (1) | MXPA04008881A (OSRAM) |
| NO (1) | NO20044279L (OSRAM) |
| NZ (1) | NZ535427A (OSRAM) |
| PE (1) | PE20040157A1 (OSRAM) |
| PL (1) | PL372490A1 (OSRAM) |
| PT (1) | PT1482925E (OSRAM) |
| RS (1) | RS89504A (OSRAM) |
| RU (1) | RU2314299C2 (OSRAM) |
| TW (1) | TW200307674A (OSRAM) |
| UA (1) | UA78027C2 (OSRAM) |
| UY (1) | UY27715A1 (OSRAM) |
| WO (1) | WO2003075915A1 (OSRAM) |
Families Citing this family (32)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE102004062182B4 (de) * | 2004-12-20 | 2007-06-06 | Bayer Schering Pharma Ag | Transdermales Pflaster mit Progesteron A-Spezifische Liganden (PRASL) als Wirkstoff |
| US20070015689A1 (en) * | 2005-06-23 | 2007-01-18 | Alza Corporation | Complexation of metal ions with polypeptides |
| US7408060B2 (en) | 2005-06-24 | 2008-08-05 | Schering Ag | Nonsteroidal progesterone receptor modulators |
| DE102005030294A1 (de) * | 2005-06-24 | 2007-01-04 | Schering Ag | Nichtsteroidale Progesteronrezeptor-Modulatoren |
| US7261742B2 (en) | 2005-10-13 | 2007-08-28 | S.C. Johnson & Son, Inc. | Method of deodorizing a textile |
| AU2006324090B2 (en) * | 2005-12-09 | 2012-05-31 | F. Hoffmann-La Roche Ag | Propionamide compounds as antiinflammatory agents |
| WO2007065828A1 (en) * | 2005-12-09 | 2007-06-14 | F. Hoffmann-La Roche Ag | Glucocorticoid receptor modulators as antiinflammatory agents |
| UY30805A1 (es) * | 2006-12-21 | 2008-07-31 | Bayer Schering Pharma Ag | Moduladores no esteroides de receptores de progesterona |
| DE102006061913A1 (de) * | 2006-12-21 | 2008-06-26 | Bayer Schering Pharma Aktiengesellschaft | Nichtsteroidale Progesteronrezeptor-Modulatoren |
| CN101289408B (zh) * | 2007-04-18 | 2013-02-27 | 中国科学院上海药物研究所 | 非甾体类孕激素受体调节剂及其制备方法、药物组合物和用途 |
| DE102007032800A1 (de) | 2007-07-10 | 2009-01-15 | Bayer Schering Pharma Aktiengesellschaft | Nichtsteroidale Progesteronrezeptor-Modulatoren |
| DE102007058747A1 (de) | 2007-12-05 | 2009-06-10 | Bayer Schering Pharma Aktiengesellschaft | Nichtsteroidale Progesteronrezeptor-Modulatoren |
| EA201070715A1 (ru) * | 2007-12-20 | 2011-02-28 | Тева Вимен'С Хелс, Инк. | Режимы дозирования, фармацевтические композиции и упаковки для экстренной контрацепции |
| RS62297B1 (sr) | 2011-11-23 | 2021-09-30 | Therapeuticsmd Inc | Prirodne kombinovane hormonske supstitucione formulacije i terapije |
| US9301920B2 (en) | 2012-06-18 | 2016-04-05 | Therapeuticsmd, Inc. | Natural combination hormone replacement formulations and therapies |
| US10806697B2 (en) | 2012-12-21 | 2020-10-20 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
| US10806740B2 (en) | 2012-06-18 | 2020-10-20 | Therapeuticsmd, Inc. | Natural combination hormone replacement formulations and therapies |
| US20150196640A1 (en) | 2012-06-18 | 2015-07-16 | Therapeuticsmd, Inc. | Progesterone formulations having a desirable pk profile |
| US20130338122A1 (en) | 2012-06-18 | 2013-12-19 | Therapeuticsmd, Inc. | Transdermal hormone replacement therapies |
| US10568891B2 (en) | 2012-12-21 | 2020-02-25 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
| US11266661B2 (en) | 2012-12-21 | 2022-03-08 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
| US11246875B2 (en) | 2012-12-21 | 2022-02-15 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
| US10471072B2 (en) | 2012-12-21 | 2019-11-12 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
| US9180091B2 (en) | 2012-12-21 | 2015-11-10 | Therapeuticsmd, Inc. | Soluble estradiol capsule for vaginal insertion |
| US10537581B2 (en) | 2012-12-21 | 2020-01-21 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
| US20160303242A1 (en) | 2013-12-09 | 2016-10-20 | Durect Corporation | Pharmaceutically Active Agent Complexes, Polymer Complexes, and Compositions and Methods Involving the Same |
| RU2016143081A (ru) | 2014-05-22 | 2018-06-26 | Терапьютиксмд, Инк. | Натуральные комбинированные гормонозаместительные составы и терапии |
| US10328087B2 (en) | 2015-07-23 | 2019-06-25 | Therapeuticsmd, Inc. | Formulations for solubilizing hormones |
| US9931349B2 (en) | 2016-04-01 | 2018-04-03 | Therapeuticsmd, Inc. | Steroid hormone pharmaceutical composition |
| US10286077B2 (en) | 2016-04-01 | 2019-05-14 | Therapeuticsmd, Inc. | Steroid hormone compositions in medium chain oils |
| CA3062732C (en) | 2017-05-10 | 2023-08-01 | Ventana Medical Systems, Inc. | Stabilized two-part hematoxylin solution utilizing ph adjustment |
| US11633405B2 (en) | 2020-02-07 | 2023-04-25 | Therapeuticsmd, Inc. | Steroid hormone pharmaceutical formulations |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8617653D0 (en) * | 1986-07-18 | 1986-08-28 | Ici Plc | Amide derivatives |
| DE19723722A1 (de) * | 1997-05-30 | 1998-12-10 | Schering Ag | Nichtsteroidale Gestagene |
| US6245804B1 (en) * | 1997-05-30 | 2001-06-12 | Schering Aktiengesellschaft | Nonsteroidal gestagens |
| NO312255B1 (no) * | 2000-06-28 | 2002-04-15 | Pgs Reservoir Consultants As | Verktöy for gjennomhulling av et langsgående veggparti av et fôringsrör |
| DE10038639A1 (de) * | 2000-07-28 | 2002-02-21 | Schering Ag | Nichtsteroidale Entzündungshemmer |
| JP2004516841A (ja) * | 2000-12-28 | 2004-06-10 | シエーリング アクチエンゲゼルシャフト | プロゲステロンレセプターアイソフォーム特異的リガンドおよび組織選択的プロゲステロンレセプターリガンドについてスクリーニングする方法 |
-
2003
- 2003-03-10 RS YU89504A patent/RS89504A/sr unknown
- 2003-03-10 IL IL16403203A patent/IL164032A0/xx unknown
- 2003-03-10 EP EP03743862A patent/EP1482925B1/en not_active Expired - Lifetime
- 2003-03-10 AU AU2003209720A patent/AU2003209720A1/en not_active Abandoned
- 2003-03-10 CN CNA038106590A patent/CN1652768A/zh active Pending
- 2003-03-10 DK DK03743862T patent/DK1482925T3/da active
- 2003-03-10 ES ES03743862T patent/ES2280766T3/es not_active Expired - Lifetime
- 2003-03-10 CA CA002478948A patent/CA2478948A1/en not_active Abandoned
- 2003-03-10 HR HRP20040923 patent/HRP20040923A2/hr not_active Application Discontinuation
- 2003-03-10 PL PL03372490A patent/PL372490A1/xx not_active Application Discontinuation
- 2003-03-10 DE DE60311236T patent/DE60311236T2/de not_active Expired - Fee Related
- 2003-03-10 WO PCT/EP2003/002441 patent/WO2003075915A1/en not_active Ceased
- 2003-03-10 RU RU2004130430/04A patent/RU2314299C2/ru not_active IP Right Cessation
- 2003-03-10 NZ NZ535427A patent/NZ535427A/en unknown
- 2003-03-10 BR BR0308394-2A patent/BR0308394A/pt not_active IP Right Cessation
- 2003-03-10 PT PT03743862T patent/PT1482925E/pt unknown
- 2003-03-10 JP JP2003574190A patent/JP2005526064A/ja active Pending
- 2003-03-10 MX MXPA04008881A patent/MXPA04008881A/es not_active Application Discontinuation
- 2003-03-11 PE PE2003000244A patent/PE20040157A1/es not_active Application Discontinuation
- 2003-03-11 AR ARP030100820A patent/AR035904A1/es active IP Right Grant
- 2003-03-11 TW TW092105213A patent/TW200307674A/zh unknown
- 2003-03-11 UY UY27715A patent/UY27715A1/es not_active Application Discontinuation
- 2003-03-11 US US10/384,775 patent/US7388006B2/en not_active Expired - Fee Related
- 2003-10-03 UA UA20041008153A patent/UA78027C2/uk unknown
-
2004
- 2004-09-21 CR CR7490A patent/CR7490A/es not_active Application Discontinuation
- 2004-10-08 NO NO20044279A patent/NO20044279L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| AR035904A1 (es) | 2004-07-28 |
| ES2280766T3 (es) | 2007-09-16 |
| US7388006B2 (en) | 2008-06-17 |
| HRP20040923A2 (en) | 2004-12-31 |
| JP2005526064A (ja) | 2005-09-02 |
| NO20044279L (no) | 2004-12-08 |
| WO2003075915A1 (en) | 2003-09-18 |
| PE20040157A1 (es) | 2004-06-03 |
| RU2314299C2 (ru) | 2008-01-10 |
| UA78027C2 (en) | 2007-02-15 |
| BR0308394A (pt) | 2005-01-25 |
| RS89504A (sr) | 2006-10-27 |
| CN1652768A (zh) | 2005-08-10 |
| PL372490A1 (en) | 2005-07-25 |
| RU2004130430A (ru) | 2005-08-10 |
| US20030232824A1 (en) | 2003-12-18 |
| EP1482925B1 (en) | 2007-01-17 |
| AU2003209720A1 (en) | 2003-09-22 |
| CA2478948A1 (en) | 2003-09-18 |
| TW200307674A (en) | 2003-12-16 |
| IL164032A0 (en) | 2005-12-18 |
| DK1482925T3 (da) | 2007-05-14 |
| PT1482925E (pt) | 2007-04-30 |
| EP1482925A1 (en) | 2004-12-08 |
| DE60311236T2 (de) | 2008-02-14 |
| DE60311236D1 (de) | 2007-03-08 |
| CR7490A (es) | 2006-02-07 |
| MXPA04008881A (es) | 2004-12-07 |
| NZ535427A (en) | 2006-08-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ECSP044992A (es) | Inhibidores de la alquín-aril fosfodiesterasa-4 | |
| NO20070373L (no) | Aerosol suspensjonsformulering inneholdende TG 227 EA eller TG 134 A som et drivmiddel | |
| ECSP045081A (es) | Derivados de 1,8-naftiridina y su uso para el tratamiento de la diabetes y trastornos relacionados | |
| ATE269312T1 (de) | N-(amidinophenyl)-n'-(subst.)-3h-2,4- benzodiazepin-3-on derivative als faktor xa inhibitoren | |
| ATE537141T1 (de) | Bicycloesterderivat | |
| EA200200571A1 (ru) | Новая композиция и ее применение | |
| DE60312972D1 (de) | Produktabgabevorrichtung und träger | |
| CY1117029T1 (el) | Συνεργιστικοι μυκητοκτονοι συνδυασμοι δραστικων ουσιων | |
| CR8481A (es) | Derivados de triazol como antagonistas de la vasopresina | |
| UY27446A1 (es) | Nuevos compuestos | |
| EA200300323A1 (ru) | ПРОИЗВОДНЫЕ ГУАНИДИНОБЕНЗАМИДА (ВАРИАНТЫ), КОМПОЗИЦИЯ (ВАРИАНТЫ), СПОСОБ ЛЕЧЕНИЯ ОПОСРЕДОВАННОГО mc4-r ЗАБОЛЕВАНИЯ (ВАРИАНТЫ) | |
| AR022636A1 (es) | Derivados de la 16-halo-epotilona, los procedimientos para prepararlos y el empleo farmaceutico de los mismos | |
| AR005703A1 (es) | Oxazolidinonas sustituidas, procedimiento para su preparacion, uso de las mismas para preparar medicamentos y medicamentos que las contienen | |
| ATE325093T1 (de) | ß2-OXO-1-PYRROLIDINDERIVATE UND IHRE PHARMAZEUTISCHE VERWENDUNGß | |
| BR0313747A (pt) | Inibidores de transcriptase reversa de não-nucleosìdeo | |
| UY27455A1 (es) | Derivados n-(1,4,5,6-tetrahidro-ciclopentapirazol -3-il)- sustituidos. su obtención y uso como fármacos. | |
| DE60230127D1 (de) | Inhibitoren von integrin alpha-v-beta-6 | |
| BR0314058A (pt) | Composições para cuidados pessoais a base de álcool ramificado | |
| UY27969A1 (es) | Formulaciones que comprenden un compuesto de indolinona | |
| CY1109581T1 (el) | Εστερες στη θεση 20 των καμπτοθεκινων | |
| ECSP055701A (es) | Nuevos derivados de pirimidinamida y el uso de los mismos | |
| CR8147A (es) | Derivados de pirido 2, 1a-isoquinolina, como inhibidores de dpp-iv | |
| DE60310767D1 (de) | PYRAZOL-3,4-d-PYRIMIDINDERIVATE UND IHRE VERWENDUNG BEI DER BEHANDLUNG VON H.PYLORI-INFEKTIONEN | |
| NO923721L (no) | 4-desoksy-4-epipodophyllotoxin-derivat eller farmasoeytiskakseptabelt salt derav | |
| RU2002107079A (ru) | Вещество, обладающее седативным действием |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 109 | Application deemed to be withdrawn |
Effective date: 20150126 |